Nuocheng Jianhua: Legal Opinion of Shanghai Fangda Law Firm on the Public Solicitation of Authorized Voting Rights of Independent Non-Executive Directors of InnoCare Pharma Limited (InnoCare Pharma Limited)
Nuocheng Jianhua: Announcement of the resolution of the board of directors of Nuocheng Jianhua Pharmaceutical Co., Ltd.
Nuochengjianhua: Self-inspection report of Nuochengjianhua Pharmaceutical Co., Ltd. on the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan insider information insider\'s stock trading situation
Nuochengjianhua: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders (Extraordinary General Meeting of Shareholders) of Nuochengjianhua Pharmaceutical Co., Ltd.
Nuocheng Jianhua: List of incentive recipients granted for the first time in the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan of Nuocheng Jianhua Pharmaceutical Co., Ltd. (as of the date of first award)
Nuocheng Jianhua: Legal Opinion of Shanghai Fangda Law Firm on matters relating to the first grant of the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan by InnoCare Pharma Limited (InnoCare Pharma Limited)
Nuocheng Jianhua: Legal Opinion of Shanghai Fangda Law Firm on the 2024 First Extraordinary General Meeting of Shareholders (Extraordinary General Meeting of Shareholders) of InnoCare Pharma Limited (InnoCare Pharma Limited)
Nuochengjianhua: Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on granting restricted shares to incentive recipients for the first time
Nuochengjianhua: Independent Financial Advisory Report of Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. on the first grant of Nuochengjianhua Pharmaceutical Co., Ltd.\'s 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan
Nuochengjianhua Pharmaceutical Co., Ltd. 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan first award list (as of the date of first award)
Legal opinion from Shanghai Fangda Law Firm on matters relating to the first grant of the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan by InnoCare Pharma Limited (InnoCare Pharma Limited)
Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on granting restricted shares to incentive recipients for the first time
Nuochengjianhua Pharmaceutical Co., Ltd.\'s self-inspection report on the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan insider information insider\'s stock trading situation
Independent Financial Advisory Report of Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. on the first grant of Nuochengjianhua Pharmaceutical Co., Ltd.\'s 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan
Announcement of Board Resolutions of Nuochengjianhua Pharmaceutical Co., Ltd.
Legal Opinion of Shanghai Fangda Law Firm on the Public Solicitation of Independent Non-Executive Directors of InnoCare Pharma Limited (InnoCare Pharma Limited) to Delegate Voting
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders (Extraordinary General Meeting of Shareholders) of Nuocheng Jianhua Pharmaceutical Co., Ltd.
Legal Opinion of Shanghai Fangda Law Firm on the 2024 First Extraordinary General Meeting of Shareholders (Extraordinary General Meeting of Shareholders) of InnoCare Pharma Limited (InnoCare Pharma Limited)
Nuochengjianhua: Explanation of the inspection opinions and publicity of Nuochengjianhua Pharmaceutical Co., Ltd. on the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan for the first time
Explanation of the inspection opinions and publicity of Nuochengjianhua Pharmaceutical Co., Ltd. on the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan for the first time